ArticleScientific reports2025
Deep learning for retinal non-perfusion and foveal avascular zone analysis in wide-field OCTA in diabetic retinopathy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Evaluation of Vascular Biomarkers in Diabetic Retinopathy Using Ultrawide-Field Swept-Source Optical Coherence Tomography Angiography: The DRIVE Study.Investigative ophthalmology & visual science · 2026Article
- Interpretable Machine Learning-Based Concentric Regional Analysis of OCTA Images for Enhanced Diabetic Retinopathy Detection.Bioengineering (Basel, Switzerland) · 2026Article
- Automated Nonperfusion Quantification in Diabetic Retinopathy on Ultra-Widefield Swept-Source OCT Angiography.Ophthalmology science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We developed an automated framework for segmenting low-quality and non-perfusion areas in widefield OCTA images to obtain two key metrics useful for diabetic retinopathy (DR) monitoring: the retinal non-perfusion index (NPI) and foveal avascular zone (FAZ) area. Using 170 images from 88 patients in the EVIRED cohort, we trained two models: Q-NET, which segments low-quality areas, and NPA-NET, which detects non-perfusion areas and the FAZ. Their combined outputs created a 4-class map to calculate NPI and FAZ area. Ground truth segmentations were established by a single expert (for non-perfusion and FAZ areas) or a consensus of four annotators (for low-quality areas). NPA-NET and Q-NET, tested on 29 images, achieved strong segmentation performances (Dice coefficients of 0.714 (low-quality), 0.781 (non-perfusion), and 0.879 (FAZ)). Some inter-annotator variability was found (mean Dice: 0.85 for low-quality, 0.683 for non-perfusion areas). Predictive accuracy for NPI and FAZ area was high, with R² coefficients of 0.97 and 0.63, respectively, with minimal underestimation and no overestimation. This AI tool provides reliable biomarkers for DR monitoring, supporting treatment decisions and medical decision-making by automatically analyzing OCTA images, and could be integrated into clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.